Gast ::
| Hauptseite > Publikationsdatenbank > Photopenic Defects in Gliomas With Amino-Acid PET and Relative Prognostic Value > print |
| Hauptseite > Publikationsdatenbank > Photopenic Defects in Gliomas With Amino-Acid PET and Relative Prognostic Value > print |
| 001 | 890483 | ||
| 005 | 20210930133536.0 | ||
| 024 | 7 | _ | |a 10.1097/RLU.0000000000003240 |2 doi |
| 024 | 7 | _ | |a 0363-9762 |2 ISSN |
| 024 | 7 | _ | |a 1536-0229 |2 ISSN |
| 024 | 7 | _ | |a 2128/28671 |2 Handle |
| 024 | 7 | _ | |a altmetric:88496013 |2 altmetric |
| 024 | 7 | _ | |a pmid:32804767 |2 pmid |
| 024 | 7 | _ | |a WOS:000600422200022 |2 WOS |
| 037 | _ | _ | |a FZJ-2021-00991 |
| 041 | _ | _ | |a English |
| 082 | _ | _ | |a 610 |
| 100 | 1 | _ | |a Zaragori, Timothée |0 P:(DE-HGF)0 |b 0 |e Corresponding author |
| 245 | _ | _ | |a Photopenic Defects in Gliomas With Amino-Acid PET and Relative Prognostic Value |
| 260 | _ | _ | |a [S.l.] |c 2021 |b Ovid |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1632206040_23426 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 520 | _ | _ | |a The aim is to explore the concept of photopenic defects in newly diagnosed glioma patients with the 2 widely used 11C-MET and 18F-FDOPA PET amino acid tracers. Thirty-two 11C-MET and 26 18F-FDOPA PET scans with amino acid PET-negative gliomas were selected in this European multicentric study. Of these gliomas, 16 11C-MET and 10 18F-FDOPA PET scans with photopenic defects were identified, exhibiting lower mean tumor-to-background ratio as compared with isometabolic gliomas (P < 0.001). Gliomas with photopenic defects had no different progression-free survival than isometabolic gliomas in the whole population (P = 0.40), but shorter progression-free survival in the subgroup of World Health Organization grade II IDH-mutant astrocytomas (35 vs 68 months; P = 0.047). |
| 536 | _ | _ | |a 525 - Decoding Brain Organization and Dysfunction (POF4-525) |0 G:(DE-HGF)POF4-525 |c POF4-525 |f POF IV |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef |
| 700 | 1 | _ | |a Castello, Angelo |0 P:(DE-HGF)0 |b 1 |
| 700 | 1 | _ | |a Guedj, Eric |0 P:(DE-HGF)0 |b 2 |
| 700 | 1 | _ | |a Girard, Antoine |0 P:(DE-HGF)0 |b 3 |
| 700 | 1 | _ | |a Galldiks, Norbert |0 P:(DE-Juel1)143792 |b 4 |u fzj |
| 700 | 1 | _ | |a Albert, Nathalie L. |0 P:(DE-HGF)0 |b 5 |
| 700 | 1 | _ | |a Lopci, Egesta |0 P:(DE-HGF)0 |b 6 |
| 700 | 1 | _ | |a Verger, Antoine |0 P:(DE-Juel1)171957 |b 7 |
| 773 | _ | _ | |a 10.1097/RLU.0000000000003240 |g Vol. 46, no. 1, p. e36 - e37 |0 PERI:(DE-600)2045053-9 |n 1 |p e36 - e37 |t Clinical nuclear medicine |v 46 |y 2021 |x 1536-0229 |
| 856 | 4 | _ | |y Published on 2021-01-01. Available in OpenAccess from 2022-01-01. |u https://juser.fz-juelich.de/record/890483/files/Zaragori_2021_Clin%20Nucl%20Med_Photopenic%20defects%20in...%20post%20print.pdf |
| 856 | 4 | _ | |y Restricted |u https://juser.fz-juelich.de/record/890483/files/Zaragori_2021_Clin%20Nucl%20Med_photopenic%20defects%20in%20gliomas....-1.pdf |
| 909 | C | O | |o oai:juser.fz-juelich.de:890483 |p openaire |p open_access |p VDB |p driver |p dnbdelivery |
| 910 | 1 | _ | |a Forschungszentrum Jülich |0 I:(DE-588b)5008462-8 |k FZJ |b 4 |6 P:(DE-Juel1)143792 |
| 913 | 1 | _ | |a DE-HGF |b Key Technologies |l Natural, Artificial and Cognitive Information Processing |1 G:(DE-HGF)POF4-520 |0 G:(DE-HGF)POF4-525 |3 G:(DE-HGF)POF4 |2 G:(DE-HGF)POF4-500 |4 G:(DE-HGF)POF |v Decoding Brain Organization and Dysfunction |x 0 |
| 913 | 0 | _ | |a DE-HGF |b Key Technologies |l Decoding the Human Brain |1 G:(DE-HGF)POF3-570 |0 G:(DE-HGF)POF3-572 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-500 |4 G:(DE-HGF)POF |v (Dys-)function and Plasticity |x 0 |
| 914 | 1 | _ | |y 2021 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2020-08-18 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2020-08-18 |
| 915 | _ | _ | |a Embargoed OpenAccess |0 StatID:(DE-HGF)0530 |2 StatID |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b CLIN NUCL MED : 2018 |d 2020-08-18 |
| 915 | _ | _ | |a IF >= 5 |0 StatID:(DE-HGF)9905 |2 StatID |b CLIN NUCL MED : 2018 |d 2020-08-18 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2020-08-18 |
| 915 | _ | _ | |a Creative Commons Attribution-NonCommercial CC BY-NC 4.0 |0 LIC:(DE-HGF)CCBYNC4 |2 HGFVOC |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2020-08-18 |
| 915 | _ | _ | |a Allianz-Lizenz |0 StatID:(DE-HGF)0410 |2 StatID |d 2020-08-18 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2020-08-18 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1110 |2 StatID |b Current Contents - Clinical Medicine |d 2020-08-18 |
| 915 | _ | _ | |a Nationallizenz |0 StatID:(DE-HGF)0420 |2 StatID |d 2020-08-18 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2020-08-18 |
| 920 | _ | _ | |l yes |
| 920 | 1 | _ | |0 I:(DE-Juel1)INM-3-20090406 |k INM-3 |l Kognitive Neurowissenschaften |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a UNRESTRICTED |
| 980 | _ | _ | |a I:(DE-Juel1)INM-3-20090406 |
| 980 | 1 | _ | |a FullTexts |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|